Iskani rezultati za avtorja

1

Systemic mast cell disease: A clinical and hematopathologic study of 26 cases od Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

Izdano 1982

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
2

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes od Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

Izdano 2001

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
3

Treatment of Systemic Mast-Cell Disease with Cladribine od Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

Izdano 2001

Polni tekst Polni tekst
Carta

Dodaj v priljubljene

Shranjeno v:
4

Epstein-Barr virus infection in Richter's transformation od Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

Izdano 1999

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
5

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... od Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

Izdano 2009

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
6

Systemic Mast Cell Disease od William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

Izdano 1988

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
7

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study od David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

Izdano 2002

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
8

Significance of systemic mast cell disease with associated hematologic disorders od William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

Izdano 1988

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
9

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases od Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

Izdano 2004

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
10

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia od Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

Izdano 2001

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
11

Validation and comparison of contemporary prognostic models in primary myelofibrosis od Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

Izdano 2007

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
12

Risk factors for leukemic transformation in patients with primary myelofibrosis od Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

Izdano 2008

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
13

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults od Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

Izdano 2010

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
14

Thalidomide treatment in myelofibrosis with myeloid metaplasia od Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

Izdano 2002

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
15

The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates od Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

Izdano 2005

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
16

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 od Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

Izdano 2010

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
17

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors od Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

Izdano 2009

Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
18

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia od Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Izdano 2007

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
19

Concomitant neutrophil JAK2V617F mutation screening and PRV‐1 expression analysis in myeloproliferative disorders and secondary polycythaemia od Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho, Susan M. Schwager, Chin‐Yang Li, David Dingli, Alexandra P. Wolanskyj, David P. Steensma, Ruben A. Mesa, D. Gary Gilliland

Izdano 2005

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:
20

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia od Animesh Pardanani, Stephanie R. Brockman, Sarah F. Paternoster, Heather C. Flynn, Rhett P. Ketterling, Terra L. Lasho, Ching-Liang Ho, Chin‐Yang Li, Gordon W. Dewald, Ayalew Tefferi

Izdano 2004

Polni tekst Polni tekst
Artigo

Dodaj v priljubljene

Shranjeno v:

Systemic mast cell disease: A clinical and hematopathologic study of 26 cases od Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes od Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

Treatment of Systemic Mast-Cell Disease with Cladribine od Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

Epstein-Barr virus infection in Richter's transformation od Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... od Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

Systemic Mast Cell Disease od William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study od David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

Significance of systemic mast cell disease with associated hematologic disorders od William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases od Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia od Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

Validation and comparison of contemporary prognostic models in primary myelofibrosis od Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

Risk factors for leukemic transformation in patients with primary myelofibrosis od Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults od Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

Thalidomide treatment in myelofibrosis with myeloid metaplasia od Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates od Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 od Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors od Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia od Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Rezultati - Chin‐Yang Li

Systemic mast cell disease: A clinical and hematopathologic study of 26 cases od Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes od Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

Treatment of Systemic Mast-Cell Disease with Cladribine od Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

Epstein-Barr virus infection in Richter's transformation od Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... od Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

Systemic Mast Cell Disease od William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study od David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

Significance of systemic mast cell disease with associated hematologic disorders od William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases od Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia od Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

Validation and comparison of contemporary prognostic models in primary myelofibrosis od Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

Risk factors for leukemic transformation in patients with primary myelofibrosis od Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults od Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

Thalidomide treatment in myelofibrosis with myeloid metaplasia od Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates od Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 od Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors od Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia od Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Iskalna orodja:

Sorodne teme